| The potential of medical abortion to reduce maternal mortality in Africa: what benefits for Tanzania and Ethiopia? | |
| | |
MedLine Citation:
|
PMID: 20948995 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
BACKGROUND: Unsafe abortion is estimated to account for 13% of maternal mortality globally. Medical abortion is a safe alternative. METHODS: By estimating mortality risks for unsafe and medical abortion and childbirth for Tanzania and Ethiopia, we modelled changes in maternal mortality that are achievable if unsafe abortion were replaced by medical abortion. We selected Ethiopia and Tanzania because of their high maternal mortality ratios (MMRatios) and contrasting situations regarding health care provision and abortion legislation. We focused on misoprostol-only regimens due to the drug's low cost and accessibility. We included the impact of medical abortion on women who would otherwise choose unsafe abortion and on women with unwanted/mistimed pregnancies who would otherwise carry to term. RESULTS: Thousands of lives could be saved each year in each country by implementing medical abortion using misoprostol (2122 in Tanzania and 2551 in Ethiopia assuming coverage equals family planning services levels: 56% for Tanzania, 31% for Ethiopia). Changes in MMRatios would be less pronounced because the intervention would also affect national birth rates. CONCLUSIONS: This is the first analysis of impact of medical abortion provision which takes into account additional potential users other than those currently using unsafe abortion. Thousands of women's lives could be saved, but this may not be reflected in as substantial changes in MMRatios because of medical abortion's demographic impact. Therefore policy makers must be aware of the inability of some traditional measures of maternal mortality to detect the real benefits offered by such an intervention. |
| | |
Authors:
|
Rebecca F Baggaley; Joanna Burgin; Oona M R Campbell |
Related Documents
:
|
11699545 - Medicine and medicalization: a response to purdy. 11499185 - Norgestimate. from the laboratory to three clinical indications. 19014795 - Medical abortion practices: a survey of national abortion federation members in the uni... 21681105 - American college of medical genetics recommendations for the design and performance exp... 17915685 - Carbonaceous aerosols in pm10 and pollution gases in winter in beijing. 10114375 - Medicare program; continuous use of durable medical equipment--hcfa. interim final rule... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-10-11 |
Journal Detail:
|
Title: PloS one Volume: 5 ISSN: 1932-6203 ISO Abbreviation: PLoS ONE Publication Date: 2010 |
Date Detail:
|
Created Date: 2010-10-15 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101285081 Medline TA: PLoS One Country: United States |
Other Details:
|
Languages: eng Pagination: e13260 Citation Subset: IM |
Affiliation:
|
Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom. r.baggaley@imperial.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Grant Support | |
ID/Acronym/Agency:
|
GR082623MA//Wellcome Trust |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Modeling and Optimization of Printed Spiral Coils in Air, Saline, and Muscle Tissue Environments.
Next Document: Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclamp...